Access Closure

Access Closure

Signal active

Organization

Contact Information

Overview

Access Closure, Inc., a medical device company, provides access site management products to address the complex challenge of vascular closure during interventional and diagnostic procedures. The company's products include Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble and extravascular sealant, which expands in the tissue tract by absorbing blood and subcutaneous fluids. Access Closure, Inc. was founded in 2002 and is based in Mountain View, California.

About

Industries

Health Care, Medical Device, Health Diagnostics

Founded

2002

Employees

251-500

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Access Closure headquartered in United States, North America, operates in the Health Care, Medical Device, Health Diagnostics sector. The company focuses on Health Care and has secured $1.2B in funding across 48 round(s). With a team of 251-500 employees, Access Closure is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - Access Closure, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Brian Armijo

Brian Armijo

VP, Operations

imagePlace L. N. Hopkins

L. N. Hopkins

Board Director

Funding Rounds

Funding rounds

4

Investors

6

Lead Investors

0

Total Funding Amount

$25.8M

Details

0

Access Closure has raised a total of $25.8M in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

Access Closure is funded by 18 investors.

Investor NameLead InvestorFunding RoundPartners
Pinnacle Ventures-FUNDING ROUND - Pinnacle Ventures10.0M
Three Arch Partners-FUNDING ROUND - Three Arch Partners10.0M
Access Closure-FUNDING ROUND - Access Closure10.0M
Integral Capital Partners-FUNDING ROUND - Integral Capital Partners10.0M

Recent Activity

There is no recent news or activity for this profile.